Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intrahepatic Cholangiocarcinoma (Icc)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04526106
What this trial is testing

REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors

Who this might be right for
FGFR2 AmplificationFGFR2 Gene MutationFGFR2 Gene Fusion/Rearrangement+5 more
Elevar Therapeutics 490
Very early researchLooking for participantsNCT06583993
What this trial is testing

A Clinical Trial Evaluating the Safety and Efficacy of Intravenous HNF4α srRNA in Treating Advanced ICC Patients

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shanghai Changzheng Hospital 9
Testing effectiveness (Phase 2)Ended earlyNCT02415036
What this trial is testing

Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma

Who this might be right for
Hepatocellular CarcinomaIntrahepatic Cholangiocarcinoma
Delcath Systems Inc. 17
Not applicableNot Yet RecruitingNCT06447454
What this trial is testing

Combining Chemoradiotherapy With Sintilimab in First-Line ICC

Who this might be right for
ICC
Shanghai Zhongshan Hospital 19
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06946849
What this trial is testing

Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Shanghai Zhongshan Hospital 76
Not applicableNot Yet RecruitingNCT07208526
What this trial is testing

Trial of Surgical Decision-Making Guided by TDTP-RECIST

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Conversion TherapyTDTP-RECIST+1 more
Shanghai Zhongshan Hospital 270
Not applicableLooking for participantsNCT07337850
What this trial is testing

Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers

Who this might be right for
Gall Bladder CancerIntrahepatic Cholangiocarcinoma (Icc)
Tata Memorial Centre 60
Early research (Phase 1)Study completedNCT01938729
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaPeripheral CholangiocarcinomaCholangiolar Carcinoma+1 more
Memorial Sloan Kettering Cancer Center 8
Testing effectiveness (Phase 2)UnknownNCT05620498
What this trial is testing

Tislelizumab Combined With Lenvatinib and GEMOX Versus Tislelizumab Combined With GEMOX in Conversion Therapy of ICC and GBC.

Who this might be right for
Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Large-scale testing (Phase 3)Looking for participantsNCT06282575
What this trial is testing

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
Jazz Pharmaceuticals 286
Not applicableStudy completedNCT07479264
What this trial is testing

A Study on Intratumoral Fibrosis and α-SMA Expression in Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
First Affiliated Hospital, Sun Yat-Sen University 169
Testing effectiveness (Phase 2)Ended earlyNCT06739252
What this trial is testing

Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Perihilar Cholangiocarcinoma
Peking University 1
Large-scale testing (Phase 3)Not Yet RecruitingNCT07328919
What this trial is testing

Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Advanced Cholangiocarcinoma
TransThera Sciences (Nanjing), Inc. 138
Not applicableNot Yet RecruitingNCT07707661
What this trial is testing

Application of Super-Resolution Ultrasound (SRUS) in Liver Tumor

Who this might be right for
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocellular CarcinomaHepatic Hemangioma+2 more
Eastern Hepatobiliary Surgery Hospital 350
Not applicableLooking for participantsNCT07176962
What this trial is testing

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

Who this might be right for
Gall Bladder CancerIntrahepatic Cholangiocarcinoma (Icc)Extrahepatic Cholangiocarcinoma+3 more
Yingbin Liu, MD, PhD, FACS 1,800
Testing effectiveness (Phase 2)Looking for participantsNCT05557578
What this trial is testing

GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence

Who this might be right for
Intrahepatic Cholangiocarcinoma
Zhejiang Cancer Hospital 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07691515
What this trial is testing

Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Zhejiang Cancer Hospital 140
Testing effectiveness (Phase 2)UnknownNCT03820310
What this trial is testing

Clinical Trial of Autologous Tcm Immunotherapy in ICC

Who this might be right for
Cholangiocarcinoma
Newish Technology (Beijing) Co., Ltd. 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128290
What this trial is testing

PErioperative CISGEM + Rilvegostomig in High-Risk Resectable Intra Hepatic CholangioCarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Federation Francophone de Cancerologie Digestive 49
Testing effectiveness (Phase 2)Looking for participantsNCT07063888
What this trial is testing

A Prospective Phase II Study of Postoperative Concurrent Chemoradiotherapy in Patients With Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Adjuvant ChemoradiotherapyNarrow Margin+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 66
Next Page